Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date: March 25, 2025
Context: The filing serves as a Regulation FD disclosure to provide shareholders with a status update regarding the FDA clearance process for the Company's Intelligent Fingerprint Drug Screening System.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused on regulatory status updates rather than financial performance.
Material Changes
No material financial changes or comparative period data are reported in this filing. The primary event is the issuance of a press release concerning the regulatory status of a specific product.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release (Exhibit 99.1) detailing the status of the FDA clearance process for its Intelligent Fingerprint Drug Screening System.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" under the Exchange Act, nor is it incorporated by reference into other filings unless specifically identified.
- Emerging Growth Company: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific details on the FDA clearance timeline and current status.
- Verify the Company's status as an emerging growth company and any associated accounting transition periods.
- Confirm that no financial data is included in this specific 8-K filing; refer to recent 10-K or 10-Q filings for financial metrics.